The Global Emerging Interventional Cardiac Devices Market

Increasing Adoption of New Technologies in Emerging Markets will Provide Impetus to Growth

Regular Price: USD 4,950.00

Special Price USD 4,455.00

10% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 4,455.00


Be the first to review this product

This research analyzes trends and revenue in the global emerging interventional cardiac devices market from 2010 to 2020, with a base year of 2013 and a forecast from 2014 to 2020. The market is divided into 5 segment modalities, including transcatheter heart valves, renal denervation, bronchial thermoplasty, bioresorbable stents, and fractional flow reserve. The geographic scope covers the United States, Europe, and Rest of World (ROW). Trends evaluated include forecast trends, challenges and opportunities, country snapshots, and key findings. Key competitor market shares are also estimated for 2013. A competitive playbook and competitive analysis are provided, and 3 big predictions close the study.

Table of Contents

Executive SummaryKey FindingsKey Findings (continued)Scope and SegmentationScope and Segmentation (continued)Key Questions This Study Will AnswerExecutive Summary—Market Engineering MeasurementsCEO’s PerspectiveExecutive Summary—3 Big PredictionsMarket OverviewMarket Overview—DefinitionsMarket Overview—Definitions (continued)Market Overview—Definitions (continued)Market Overview—Definitions (continued)Research Scope and MethodologyMarket SegmentationDefining Healthcare Trends in the FutureCompetitive PlaybookNew Market OpportunitiesNew Market Opportunities (continued)Top Competitors in Interventional CardiologyMerger, Acquisition, and Partnership AssessmentMerger, Acquisition, and Partnership Assessment (continued)Drivers, Restraints, and Trends—Total Emerging Interventional Cardiac Devices MarketDrivers and RestraintsDrivers ExplainedDrivers Explained (continued) Drivers Explained (continued)Drivers Explained (continued)Drivers Explained (continued)Restraints ExplainedRestraints Explained (continued)Forecasts and Trends—Total Emerging Interventional Cardiac Devices MarketMarket Engineering MeasurementsTAVR Segment—Revenue Forecast by RegionRenal Denervation Segment—Revenue Forecast by RegionBT Segment—Revenue Forecast by RegionBioresorbable Stents Segment—Revenue Forecast by RegionFFR Segment—Revenue Forecast by RegionSegmentation—Key HighlightsPricing AnalysisPricing Analysis (continued)Procurement ProcessGlobal Hot Spots—Shifting Strategies in the Global Market PlaceMarket Share and Competitive Analysis—Total Emerging Interventional Cardiac Devices MarketCompetitive EnvironmentTranscatheter Heart Valves Segment BreakdownTranscatheter Heart Valves Segment—OverviewTranscatheter Heart Valves Segment—Overview (continued)Transcatheter Heart Valves Segment—Market Engineering MeasurementsTranscatheter Heart Valves Segment—Revenue ForecastRevenue Forecast DiscussionRevenue Forecast Discussion (continued)Revenue Forecast Discussion (continued)Transcatheter Heart Valves Segment—Reimbursement ScenarioTranscatheter Heart Valves Segment—Market ParticipantsTranscatheter Heart Valves Segment—Comparison of Key TAVR ProductsCompetitive Analysis—Market ShareCompetitive EnvironmentRDN Segment BreakdownRDN Segment—OverviewRDN Segment—Overview (continued)RDN Segment—Market Engineering MeasurementsRDN Segment—Revenue ForecastRevenue Forecast DiscussionRevenue Forecast Discussion (continued)Revenue Forecast Discussion (continued)RDN Segment—Market ParticipantsRDN Segment—Worldwide Market Opportunity Competitive Analysis—Market ShareCompetitive EnvironmentBT Segment BreakdownBT Segment—OverviewBT Segment—Market Engineering MeasurementsBT Segment—Revenue ForecastRevenue Forecast DiscussionBT Segment—Major Market ParticipantBT Segment—Burning Away BreathlessnessCompetitive Analysis—Market ShareCompetitive EnvironmentBioresorbable Stents Segment BreakdownBioresorbable Stents Segment—OverviewBioresorbable Stents Segment—Market Engineering MeasurementsBioresorbable Stents Segment—Revenue ForecastRevenue Forecast DiscussionRevenue Forecast Discussion (continued)Bioresorbable Stents Segment—Major Market ParticipantsBioresorbable Stents Segment—Product Development StatusCompetitive Analysis—Market ShareCompetitive EnvironmentFFR Segment BreakdownFFR Segment—OverviewFFR Segment—Market Engineering MeasurementsFFR Segment—Revenue ForecastRevenue Forecast DiscussionRevenue Forecast Discussion (continued)FFR Segment—Major Market ParticipantsCompetitive Analysis—Market ShareCompetitive EnvironmentCountry Snapshot—United StatesCountry Snapshot—United StatesCountry Snapshot—United States (continued)Country Snapshot—EuropeCountry Snapshot—EuropeCountry Snapshot—Europe (continued)Country Snapshot—ROWCountry Snapshot—ROWCountry Snapshot—ROW (continued)The Last WordSeparating Winners and Losers in the New MarketplaceThe Last Word—3 Big PredictionsLegal DisclaimerAppendixMarket Engineering MethodologyDatabase of Industry ParticipantsLearn More—Next StepsDecision Support Database Decision Support Database Decision Support Database (continued) Decision Support Database (continued)

Related Research

Release Date : 11-Jul-17

Region : North America

Release Date : 19-Oct-2015

Region : North America

Release Date : 30-Sep-2015

Region : North America

Release Date : 28-Sep-2015

Region : North America

Release Date : 20-Aug-2015

Region : Asia Pacific

Release Date : 10-Jun-2015

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.